Skip to content

Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)

Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06380855
Enrollment
5
Registered
2024-04-24
Start date
2022-08-24
Completion date
2025-08-24
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

The investigators propose to use flexible endoscopy combined with transanal total mesorectal resection to further reduce anal injury.

Detailed description

Endoscopic technique has become an indispensable part of Natural orifice transluminal endoscopic surgery (NOTES). However, the upper gastrointestinal tract is easy to cause severe leakage complications, which mainly limits the application of endoscopy in rectum. Herein, investigators propose purse suture closing distal rectum and full-layer incision of the rectal wall using flexible endoscopic from anal to assist in hybrid transanal total mesorectal resection (taTME).Further reduce the damage of anus caused by taTME.

Interventions

PROCEDUREFlexible colonoscope assisted hybrid transanal total mesorectal resection

Endoscopic pursestring suture (EPSS) was performed at the distance from 1cm to the inferior edge of the tumor by a double-channel flexible colonoscope. An endoloop was inserted through one channel. Meanwhile, the endoclips was inserted through the other channel one by one to fix the endoloop around the rectal wall. And then the endoloop was tightened slowly. After completing the routine lavage lumen, a full-thickness, circumferential dissection was performed by flexible colonoscope following taTME surgical principle until it converged with the laparoscopy group.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Age between 18 and 80 years old 2. Confirmed rectal adenocarcinoma cancer pathologically 3. tumor location ≦ 12 cm from the anal margin 4. Willing and able to provide written informed consent for participation in this study

Exclusion criteria

1. distant metastasis before surgery 2. more than one colorectal tumor at diagnosis 3. familial adenomatous polyposis 4. recurrent rectal cancer 5. undergo transanal minimally invasive surgery 6. undergo palliative treatment 7. undergo emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Success rate of operation1 years after the surgeryWhether it is necessary to switch to other surgical methods

Countries

China

Contacts

Primary ContactLiang Kang, MD. and Phd.
kangl@mail.sysu.edu.cn020-38455369

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026